Public Company News
IPS Expands Long Haul Submarine Data Transmission Capacity with Ribbon's IP Optical Solutions
Leverages Apollo optical transport solutions for high capacity service connections under the South China Sea with links exceeding 2,500 km (1,500 miles) PLANO, Texas, Jan. 13, 2022 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications software a...
2022-01-13 21:00
3094
Retail Industry Reshapes with Hybrid Cloud and AI to Help Meet Shifting Consumer Shopping and Sustainability Preferences
2022 IBM/NRF global consumer study finds: - 'Hybrid shopping' is the method of choice for over one in four consumers surveyed - 62% of consumers surveyed are willing to change their purchasing habits to reduce environmental impact, but intention/action gap remains ARMONK, N.Y., Jan. 13, 2022 /P...
2022-01-13 21:00
3498
Mindtree Reports Strong Performance in Q3 FY22
BANGALORE, India and WARREN, N.J., Jan. 13, 2022 /PRNewswire/ -- Mindtree
2022-01-13 19:50
3700
JinkoSolar's Subsidiary Jinko Solar Co., Ltd.'s IPO Pricing Announced by the Shanghai Stock Exchange
SHANGRAO, China, Jan. 13, 2022 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, is in the process of applying for an initial public offering ("IPO") of the Company's principal ...
2022-01-13 19:24
4907
ReneSola Power to Participate in the Sidoti Virtual Small Cap Conference
STAMFORD, Conn., Jan. 13, 2022 /PRNewswire/ -- ReneSola Ltd ("ReneSola Power"
or the "Company") (www.renesolapower.com
2022-01-13 19:00
2297
Veoneer's Research Tech Talk "Trust in Collaborative - and Self-Driving - What's Next?" Published Virtually
STOCKHOLM, Jan. 13, 2022 /PRNewswire/ -- The automotive technology company Veoneer, Inc.(NYSE: VNE) (SSE: VNE SDB), has published its 2022 Research Tech Talk, "Trust in Collaborative - and Self-Driving - What's Next?", where thought leaders discuss the power and potential of the expanding world o...
2022-01-13 17:54
3109
Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of FASN Inhibitor ASC40 for Treatment of Moderate to Severe Acne
HANGZHOU and SHAOXING, China, Jan. 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first patient in the Phase II clinical trial of ASC40 for moderate to severe acne. ASC40 is an oral, selective inhibitor of fatty acid synthase (FASN), a key enzyme whic...
2022-01-13 17:30
4580
HeiQ Launches World's First Dual Action Textile Cooling Technology
ZÜRICH, Jan. 13, 2022 /PRNewswire/ -- HeiQ announces the launch of a new dual
action textile cooling technology, HeiQ Cool, the world's first textile
technology to deliver both instant contact cooling and continuous evaporative
cooling.
2022-01-13 17:00
4488
TuanChe Announces Unaudited Third Quarter 2021 Financial Results
BEIJING, Jan. 13, 2022 /PRNewswire/ -- TuanChe Limited ("TuanChe," "Company," "we" or "our") (NASDAQ: TC), a leading integrated automotive marketplace inChina , today announced its unaudited financial results for the third quarter ended September 30, 2021. Key Third Quarter 2021 Financial and Op...
2022-01-13 15:00
4678
Enrollment Completed in Phase II Clinical Study of KN026 Combined with KN046
* Interim analysis expected in the second quarter of 2022 SUZHOU, China, Jan. 13, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the phase II clinical study of KN026 (HER2 bispecific antibody) combined with KN046 (PD-L1/CTLA-4 bispecific antibody) (KN026-203) has su...
2022-01-13 10:46
3801
Samsung Biologics Shares Strategic Roadmap for Sustainable Growth at the 40th Annual JP Morgan Healthcare Conference
INCHEON, South Korea, Jan. 12, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced its sustainable growth plan for this year at the 2022 Annual JP Morgan Healthcare Conference, which is held virtually fromJanuary 10th to 13th with leaders from major pharmaceutical and biopharmaceuti...
2022-01-13 08:52
2621
CStone announces phase 2 GEMSTONE-201 trial met primary endpoint of objective response rate (ORR) in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL)
* Sugemalimab has the potential to become the world's first immunotherapy to be approved for patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL) * The National Medical Products Administration (NMPA) of China has granted the Breakthrough Therapy Designati...
2022-01-13 08:05
7496
GreenTree Hospitality Group Ltd. Reports Third Quarter 2021 Financial Results
* Total revenues increased 16.3% year-over-year to RMB310.4 million (US$48.2 million)[1]. * Income from operations decreased 45.6% year-over-year to RMB54.9 million ( US$8.5 million) [1]. * Adjusted EBITDA (non-GAAP) [2] decreased 33.5% year-over-year to RMB73.7 million (US$11.4 million) [1]...
2022-01-13 07:20
4792
Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference
SEOUL, South Korea, Jan. 13, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics (MDx) company, today, unveiled its blueprint for the future during a presentation at the 40th annual J.P. Morgan Healthcare virtual Conference. Dr.Jong-Yoon Chun, CEO of Seegene...
2022-01-13 04:00
3614
Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000
* Single-ascending-dose (SAD) study successfully demonstrated the safety, tolerability, and sustained release profile at least 3 months resulting from ALA-1000 injection in patients with opioid dependence. TAICHUNG, Taiwan, Jan. 12, 2022 /PRNewswire/ -- Alar Pharmaceuticals Inc. (Alar, TWSE:67...
2022-01-13 00:00
2876
Bon Natural Life Limited Received Initial Purchase Order for its Stachyose and Apple Extract based Personal Care Products
XIAN, China, Jan. 12, 2022 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has received an initial purchase order (the "Order") from ...
2022-01-12 21:30
4391
51job, Inc. Announces Receipt of a Proposal to Amend Merger Consideration for Going-Private Transaction
SHANGHAI, Jan. 12, 2022 /PRNewswire/ -- 51job, Inc. (Nasdaq: JOBS) ("51job" or the "Company"), a leading provider of integrated human resource services in China, announced today that its Board of Directors (the "Board") and the special committee of the Board (the "Special Committee") have receive...
2022-01-12 21:30
4780
Gracell Biotechnologies Unveils Innovation Center in U.S.
SUZHOU, China and PALO ALTO, Calif., Jan. 12, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, toda...
2022-01-12 21:00
2026
I-Mab Announces First Patient Dosed in China Phase 2 Clinical Trial of Efineptakin Alfa in Combination with Pembrolizumab in Advanced Solid Tumors
SHANGHAI and GAITHERSBURG, Md., Jan. 12, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the first patient had been dosed in itsChina phase...
2022-01-12 21:00
2108
Infosys: Revenue guidance for FY22 revised upwards to 19.5%-20.0%, powered by sequential growth of 7.0% in Q3
BENGALURU, India, Jan. 12, 2022 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered strong Q3 performance with sequential growth of 7.0% in a seasonally weak quarter and year-on-year growth of 21.5% in constan...
2022-01-12 20:53
10221
Week's Top Stories
Most Reposted
Visa Destinations Launches in Asia Pacific as Regional Travel Remains Resilient
[Picked up by 329 media titles]
2026-05-05 10:01Agoda Makes it Easier for Travelers to See Relevant Photos in Reviews
[Picked up by 311 media titles]
2026-05-06 12:00
AVPN AI Opportunity Fund Expands to Build AI-Ready Generations Across Asia by Empowering Educators and Youth Across Asia-Pacific
[Picked up by 296 media titles]
2026-05-05 09:00Colebrook Bosson Saunders Expands Flo X Multi Compatibility for Curved Ultrawide Monitors
[Picked up by 288 media titles]
2026-05-05 11:00
MetaOptics - Update on Proposed Nasdaq Dual Listing
[Picked up by 282 media titles]
2026-05-05 08:00Most Read
DMALL Gains Momentum in Southeast Asia with AI-Driven Retail Platform
2026-05-04 13:33
6995
Visa Destinations Launches in Asia Pacific as Regional Travel Remains Resilient
2026-05-05 10:01
6917
Blaize and Winmate Sign Strategic Partnership Agreement to Bring AI to Rugged Systems for Defense and Critical Infrastructure
2026-05-04 19:00
6711
